ISSN |
1948-5190 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence
|
Manuscript Source |
Invited Manuscript |
All Author List |
Andrew Chan, Hamish Philpott, Amanda H Lim, Minnie Au, Derrick Tee, Damian Harding, Mohamed Asif Chinnaratha, Biju George and Rajvinder Singh |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Rajvinder Singh, FRACP, FRCP (C), MBBS, MPhil, MRCP, Professor, Department of Gastroenterology, Lyell McEwin Hospital, Haydown Road, Elizabeth Vale, Adelaide 5112, South Australia, Australia. rajvinder.singh@sa.gov.au |
Key Words |
Endoscopy; Anticoagulants; Antiplatelets; Antithrombotics; Bleeding; Gastrointestinal |
Core Tip |
The current position statements and guidelines from the major gastroenterology societies have provided endoscopists with an evidenced-based systematic approach to pre, peri and post-operative management of patients on anticoagulant and antiplatelet agents in the context of both low and high-risk endoscopic procedures. While there is sufficient evidence on the index bleeding risk in common endoscopic procedures in in the absence of anticoagulant and/or antiplatelet agents, the evidence surrounding bleeding risk while on anticoagulant and/or antiplatelet agents is variable among different publications and still evolving. In this review, we have summarised the available evidence, provided an overview, and described our recommended practical application of anticoagulant and antiplatelet management in common endoscopic procedures. Finally, we have compared our recommendations against the current guidelines from the major gastroenterology societies to assimilate a new working reference, and to highlight any knowledge gaps and directions for future research. |
Publish Date |
2020-11-16 13:22 |
Citation |
Chan A, Philpott H, Lim AH, Au M, Tee D, Harding D, Chinnaratha MA, George B, Singh R. Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence. World J Gastrointest Endosc 2020; 12(11): 408-450 |
URL |
https://www.wjgnet.com/1948-5190/full/v12/i11/408.htm |
DOI |
https://dx.doi.org/10.4253/wjge.v12.i11.408 |